Compound ID | 989
Class: Gramicidin
| Details of activity: | Unlike actinomycin, would not seem to bind/inhibit DNA/RNA polymerase. Anti-tumour antibiotic. |
| Institute where first reported: | Chester Beatty Research institute, Institute of cancer research, Royal Cancer Hospital |
| Year first mentioned: | 1966 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citations: |
|